As of October 29, GeLongHui reported that Yuhong Medicine (688176.SH) achieved total operating income of 0.139 billion yuan in the first three quarters of 2024, an increase of 4537.79% year-on-year; net income attributable to the parent company's shareholders was -0.271 billion yuan; basic earnings per share was -0.48 yuan.
亚虹医药(688176.SH)：前三季度净亏损2.71亿元
Yahong Pharmaceuticals (688176.SH): Net loss of 0.271 billion yuan in the first three quarters.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha
【November 2024】Has disney's predicament turned around? Pay attention to these 3 performance signals.
As the entertainment kingdom for nearly a century, Disney's status in Hollywood has gained prominence. Over 60 years of listing on the U.S. stock market, Disney